Article
miR-6076 rs1463411 polymorphisms are associated with bleeding during clopidogrel treatment in patients with acute coronary syndrome.
European journal of medical research - 24 Feb 2023
Mo Zhen-Zhen, Yuan Zhen, Peng Yuan-Yuan, Zhou Wan-Lu, Dai Wei, Wang Guo, Tang Jie, Zhang Wei, Chen Bi-Lian
Abstract excerpt
Bleeding is a major adverse event during clopidogrel treatment in patients with acute coronary syndrome (ACS). However, the potential mechanism affecting bleeding among individuals is unclear. Herein, we investigated the involvement of CYP2C19*2 and CYP2C19*3, as well as 10 miRNA polymorphisms, in bleeding in Chinese patients with ACS during the first year of clopidogrel treatment. The miR-6076 rs1463411 G...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
